ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,406.88
-0.38%
Dow Jones
39,869.38
0.00%
Gold vs US Dollar
2,389.07
0.45%
Brent Oil
83.355
0.18%
Bitcoin
66,358.88
1.72%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. LumiraDx Ltd (LMDX)

  7. LumiraDx Ltd (LMDX) News

LumiraDx (LMDX)

LumiraDx Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:LMDX
DateTimeSourceHeadlineSymbolCompany
05/01/202422:45GlobeNewswire Inc.LumiraDx Announces its Securities will be Suspended from Trading on Nasdaq at the Open of Business on January 9thNASDAQ:LMDXLumiraDx Ltd
29/12/202322:07Dow Jones NewsLumiraDx Agrees to Sell Point-of-Care Tech Platform to RocheNASDAQ:LMDXLumiraDx Ltd
29/12/202321:15GlobeNewswire Inc.LumiraDx Announces Agreement to Sell its Cutting Edge Point of Care Technology Platform to RocheNASDAQ:LMDXLumiraDx Ltd
27/10/202321:45GlobeNewswire Inc.LumiraDx Announces Receipt of NASDAQ Delisting Determination; Plans to AppealNASDAQ:LMDXLumiraDx Ltd
20/10/202323:34GlobeNewswire Inc.LumiraDx Partners with AstraZeneca & Everton in the Community to Set Up England’s First Heart & Lung Screening HubNASDAQ:LMDXLumiraDx Ltd
24/08/202312:45GlobeNewswire Inc.LumiraDx Reports Second Quarter 2023 ResultsNASDAQ:LMDXLumiraDx Ltd
16/08/202321:30GlobeNewswire Inc.LumiraDx to Announce Second Quarter Financial Results and Host Quarterly Conference Call on August 24NASDAQ:LMDXLumiraDx Ltd
31/07/202311:00GlobeNewswire Inc.LumiraDx’s Point of Care Diagnostics Group Continues Commercial Expansion Announcing a Distribution Agreement with Axonlab for its LumiraDx Platform and TestsNASDAQ:LMDXLumiraDx Ltd
30/06/202320:26Dow Jones NewsLumiraDx Submits Dual FDA Medical Device Application for Covid-19 TestNASDAQ:LMDXLumiraDx Ltd
30/06/202319:30GlobeNewswire Inc.LumiraDx Submits First 510(k) Application to the FDA for COVID Ultra TestNASDAQ:LMDXLumiraDx Ltd
20/06/202321:15GlobeNewswire Inc.LumiraDx Receives UK CTDA Approval for COVID Ultra and COVID & RSV TestsNASDAQ:LMDXLumiraDx Ltd
16/05/202312:45GlobeNewswire Inc.LumiraDx Reports First Quarter 2023 ResultsNASDAQ:LMDXLumiraDx Ltd
09/05/202321:15GlobeNewswire Inc.LumiraDx to Announce First Quarter Financial Results and Host Quarterly Conference Call on May 16NASDAQ:LMDXLumiraDx Ltd
24/04/202321:21GlobeNewswire Inc.LumiraDx Receives Nasdaq Notification Regarding Minimum Bid Price DeficiencyNASDAQ:LMDXLumiraDx Ltd
06/04/202314:20GlobeNewswire Inc.LumiraDx Announces Strategic Refocus and Cost Restructuring ProgramNASDAQ:LMDXLumiraDx Ltd
21/03/202311:26GlobeNewswire Inc.LumiraDx Reports Fourth Quarter and Full Year 2022 ResultsNASDAQ:LMDXLumiraDx Ltd
14/03/202312:03GlobeNewswire Inc.LumiraDx to Announce Fourth Quarter and Full Year 2022 Financial Results and Host Quarterly Conference Call on March 21NASDAQ:LMDXLumiraDx Ltd
03/03/202314:00GlobeNewswire Inc.LumiraDx to Present at Raymond James Institutional Investors ConferenceNASDAQ:LMDXLumiraDx Ltd
20/02/202316:00GlobeNewswire Inc.LumiraDx Regains Compliance with Nasdaq Continued Listing RequirementsNASDAQ:LMDXLumiraDx Ltd
06/02/202313:59Dow Jones NewsLumiraDx Gets FDA Emergency Authorization for Dual Flu-COVID TestNASDAQ:LMDXLumiraDx Ltd
06/02/202313:00GlobeNewswire Inc.LumiraDx Receives FDA Emergency Use Authorization and UK CTDA Approval for its Fast Lab Solutions Multiplex COVID and Influenza Molecular AssayNASDAQ:LMDXLumiraDx Ltd
31/01/202321:30GlobeNewswire Inc.LumiraDx Announces Commercial Shipment of its Point of Care NT-proBNP Test in Europe, Supporting Heart Health Checks in UKNASDAQ:LMDXLumiraDx Ltd
31/01/202321:15GlobeNewswire Inc.LumiraDx Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price DeficiencyNASDAQ:LMDXLumiraDx Ltd
14/12/202208:19GlobeNewswire Inc.LumiraDx Announces New Investment for Ongoing Development of its Point of Care Molecular Tuberculosis TestNASDAQ:LMDXLumiraDx Ltd
08/12/202208:01GlobeNewswire Inc.Latest Clinicians’ U.S. Survey Identifies Point of Care Testing (POCT) as a Way to Address Healthcare Bandwidth Pressures and Anticipates Future Growth of POCT in Community Testing CentersNASDAQ:LMDXLumiraDx Ltd
14/11/202214:44PR Newswire (US)LumiraDx Continues Commercial Expansion of its Rapid Microfluidic Immunoassay HbA1c TestNASDAQ:LMDXLumiraDx Ltd
14/11/202214:41PR Newswire (US)LumiraDx Continues Commercial Expansion of its Rapid Microfluidic Immunoassay HbA1c TestNASDAQ:LMDXLumiraDx Ltd
14/11/202214:41PR Newswire (Canada)LumiraDx Continues Commercial Expansion of its Rapid Microfluidic Immunoassay HbA1c TestNASDAQ:LMDXLumiraDx Ltd
14/11/202207:58GlobeNewswire Inc.LumiraDx Continues Commercial Expansion of its Rapid Microfluidic Immunoassay HbA1c TestNASDAQ:LMDXLumiraDx Ltd
14/11/202204:05TipRanksLumiraDx (LMDX) Gets a Buy from BTIGNASDAQ:LMDXLumiraDx Ltd
 Showing the most relevant articles for your search:NASDAQ:LMDX

Your Recent History

LSE
TERN
Tern
LSE
ENET
Ethernity Networks
LSE
VAST
Vast Resources
LSE
EZJ
Easyjet
LSE
GKP
Gulf Keystone Petroleum
LSE
CUSN
Cornish Metals
LSE
MIN
Minoan
LSE
CHRY
Chrysalis Investments
LSE
AAZ
Anglo Asian Mining
LSE
ORCH
Orchard Funding
LSE
THG
Thg
LSE
YU.
Yu
LSE
BIRD
Blackbird
LSE
POS
Plexus
LSE
GGP
Greatland Gold
LSE
GDR
Genedrive
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved